Patents/Assignees

Incelldx, Inc.

6 patents in portfolio

US12298309utility2025
Methods of Assaying Neoplastic and Neoplasia-related Cells and Uses Thereof
0 cites
US12228580utility2025
Methods of Assigning a COVID Pathological Type Based on a Cytokine/chemokine Panel
0 cites
US11988658utility2024
Methods of Assessing Cellular Breast Samples and Compositions for Use in Practicing the Same
0 cites
US11952373utility2024
Method of Treating Hypercytokinemia by Administering the CCR5/CCL5 (RANTES) Interaction Inhibitor Maraviroc
0 cites
US11726089utility2023
Methods of Assaying Neoplastic and Neoplasia-related Cells and Uses Thereof
0 cites
US11629196utility2023
Method of Treating Sars-cov-2-associated Hypercytokinemia by Administering a Human Monoclonal Antibody (PRO-140) That Inhibits CCR5/CCL5 Binding Interactions
0 cites